{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:31:28Z","timestamp":1761561088389},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1007\/s00393-006-0105-9","type":"journal-article","created":{"date-parts":[[2006,9,26]],"date-time":"2006-09-26T10:00:26Z","timestamp":1159264826000},"page":"497-504","source":"Crossref","is-referenced-by-count":4,"title":["Der Zusammenhang zwischen rheumatoider Arthritis und Krebs"],"prefix":"10.1007","volume":"65","author":[{"given":"P.","family":"Whelan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"105_CR1","volume":"20","author":"1","year":"2005","unstructured":"Askling J, Fored CM, Baeklund E et al. (2005) Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis Epub Apr 20","journal-title":"Ann Rheum Dis Epub Apr"},{"key":"105_CR2","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/art.11144","volume":"48","author":"Baecklund","year":"2003","unstructured":"Baecklund E, Ekborn A, Catrina AI et al. (2003) Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma. Arthritis Rheum 48: 1543\u20131550","journal-title":"Arthritis Rheum"},{"key":"105_CR3","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","volume":"54","author":"Baecklund","year":"2006","unstructured":"Baecklund E, Illiadou A, Askling J et al. (2006) Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 54: 692\u2013701","journal-title":"Arthritis Rheum"},{"key":"105_CR4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.autrev.2004.02.002","volume":"3","author":"Balandraud","year":"2004","unstructured":"Balandraud N, Roudier J, Roudier C (2004) Epstein-Barr virus and rheumatoid arthritis. Autoimmun Rev 3: 362\u2013367","journal-title":"Autoimmun Rev"},{"key":"105_CR5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.semarthrit.2005.01.008","volume":"34","author":"Balandraud","year":"2005","unstructured":"Balandraud N, Roudier J, Roudier C (2005) What are the links between Epstein-Barr virus, lymphoma, and tumor necrosis factor antagonism in rheumatoid arthritis? Semin Arthritis Rheum 34 [Suppl 1]: 31\u201333","journal-title":"Semin Arthritis Rheum"},{"key":"105_CR6","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","volume":"295","author":"Bongartz","year":"2006","unstructured":"Bongartz T, Sutton AJ, Sweeting MJ et al. (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295: 2275\u20132285","journal-title":"JAMA"},{"key":"105_CR7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/030097402760375124","volume":"31","author":"Bowman","year":"2002","unstructured":"Bowman SJ (2002) Hematological manifestations of rheumatoid arthritis. Scand J Rheumatol 31: 251\u2013259","journal-title":"Scand J Rheumatol"},{"key":"105_CR8","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1002\/art.10679","volume":"46","author":"Brown","year":"2002","unstructured":"Brown SL, Greene MH, Gershon SK et al. (2002) Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum 46: 3151\u20133158","journal-title":"Arthritis Rheum"},{"key":"105_CR9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.bor.0000126149.96627.82","volume":"16","author":"Callan","year":"2004","unstructured":"Callan MF (2004) Epstein-Barr virus, arthritis, and the development of lymphoma in arthritis patients. Curr Opin Rheumatol 16: 399\u2013405","journal-title":"Curr Opin Rheumatol"},{"key":"105_CR10","first-page":"2130","volume":"32","author":"Chakravarty","year":"2005","unstructured":"Chakravarty E, Michaud K, Wolfe F (2005) Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors. J Rheumatol 32: 2130\u20132135","journal-title":"J Rheumatol"},{"key":"105_CR11","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","volume":"359","author":"Choi","year":"2002","unstructured":"Choi HK, Hernan MA, Seeger JD et al. (2002) Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359(9313): 1173\u20131177","journal-title":"Lancet"},{"key":"105_CR12","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/ar1893","volume":"8","author":"Costenbader","year":"2006","unstructured":"Costenbader KH, Karlson EW (2006) Epstein-Barr virus and rheumatoid arthritis: is there a link? Arthritis Res Ther 8: 204","journal-title":"Arthritis Res Ther"},{"key":"105_CR13","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/art.10939","volume":"48","author":"Ekstrom","year":"2003","unstructured":"Ekstrom K, Hjalgrim H, Brandt L et al. (2003) Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives. Arthritis Rheum 48: 963\u2013970","journal-title":"Arthritis Rheum"},{"key":"105_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/03009748809102945","volume":"76","author":"Fassbender","year":"1988","unstructured":"Fassbender HG, Gay S (1988) Synovial processes in rheumatoid arthritis. Scand J Rheum 76: 1\u20137","journal-title":"Scand J Rheum"},{"key":"105_CR15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00002281-199106000-00012","volume":"3","author":"Firestein","year":"1991","unstructured":"Firestein GS (1991) The immunopathogenesis of rheumatoid arthritis. Curr Opin Rheumatol 3: 398\u2013406","journal-title":"Curr Opin Rheumatol"},{"key":"105_CR16","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/ard.2005.044784","volume":"65","author":"Franklin","year":"2006","unstructured":"Franklin J, Lunt M, Bunn D et al. (2006) Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritis. Ann Rheum Dis 65: 617\u2013622 (Epub 2005 Oct 25)","journal-title":"Ann Rheum Dis"},{"key":"105_CR17","doi-asserted-by":"crossref","first-page":"iv2","DOI":"10.1136\/ard.2004.031732","volume":"64","author":"Geborek","year":"2005","unstructured":"Geborek P, Bladstr\u00f6m A, Turesson C et al. (2005) Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas. Ann Rheum Dis 64 [Suppl 4]: iv2\u2013iv14 (Epub 2005 Feb 4)","journal-title":"Ann Rheum Dis"},{"key":"105_CR18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/jnci\/85.4.307","volume":"17","author":"Gridley","year":"1993","unstructured":"Gridley G, McLaughlin JK, Ekbom A et al. (1993) Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 17: 307\u2013311","journal-title":"J Natl Cancer Inst"},{"key":"105_CR19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ijc.11582","volume":"108","author":"Hoshida","year":"2004","unstructured":"Hoshida Y, Tomita J, Zhiming D et al. (2004) Lymphoproliferative disorders in autoimmune diseases in Japan: analysis of clinicopathological features and Epstein-Barr virus infection. Int J Cancer 108: 443\u2013449","journal-title":"Int J Cancer"},{"key":"105_CR20","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0021-9681(78)90071-1","volume":"31","author":"Isomaki","year":"1978","unstructured":"Isomaki HA, Hakulinen T, Joutsenlahti U (1978) Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chron Dis 31: 691\u2013696","journal-title":"J Chron Dis"},{"key":"105_CR21","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/1529-0131(199905)42:5<910::AID-ANR9>3.0.CO;2-D","volume":"42","author":"Karlson","year":"1999","unstructured":"Karlson EW, Lee IM, Cook NR et al. (1999) A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum 42: 910\u2013917","journal-title":"Arthritis Rheum"},{"key":"105_CR22","first-page":"326","volume":"32","author":"Louthrenoo","year":"2003","unstructured":"Louthrenoo W, Kasitanon N, Mahanuphab P et al. (2003) Kaposi\u2019s sarcoma in rheumatic diseases. Semin Arthritis Rheum 32: 326\u2013333","journal-title":"Semin Arthritis Rheum"},{"key":"105_CR23","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V99.11.3909","volume":"99","author":"Mariette","year":"2002","unstructured":"Mariette X, Cazals-Hatem D, Warszawki J et al. (2002) Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood 99: 3909\u20133915","journal-title":"Blood"},{"key":"105_CR24","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/0959-8049(96)00210-9","volume":"7","author":"Mellemkjaer","year":"1996","unstructured":"Mellemkjaer L, Linet MS (1996) Rheumatoid arthritis and cancer risk. Eur J Cancer 7: 1753\u20131757","journal-title":"Eur J Cancer"},{"key":"105_CR25","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1200\/JCO.2005.04.6227","volume":"24","author":"Mikuls","year":"2006","unstructured":"Mikuls T, Endo JO, Puumala SE et al. (2006) Prospective study of survival outcomes in Non-Hodgkin\u2019s lymphoma patients with rheumatoid arthritis. J Clin Oncol 24: 1597\u20131602 (Epub 2006 Mar 6)","journal-title":"J Clin Oncol"},{"key":"105_CR26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0002-9343(85)90240-2","volume":"78","author":"Prior","year":"1985","unstructured":"Prior P (1985) Cancer and rheumatoid arthritis: epidemiologic considerations. Am J Med 78: 15\u201321","journal-title":"Am J Med"},{"key":"105_CR27","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1200\/JCO.1996.14.6.1943","volume":"14","author":"Salloum","year":"1996","unstructured":"Salloum E, Cooper DL, Howe G et al. (1996) Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 14: 1943\u20131949","journal-title":"J Clin Oncol"},{"key":"105_CR28","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/art.20277","volume":"50","author":"Schiff","year":"2004","unstructured":"Schiff MH, DiVittorio G, Tesser J et al. (2004) The safety of anakinra in high-risk patients with active rheumatoid arthritis: six-month observations of patients with comorbid conditions. Arthritis Rheum 50: 1752\u20131760","journal-title":"Arthritis Rheum"},{"key":"105_CR29","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/ard.59.7.533","volume":"59","author":"Toussirot","year":"2000","unstructured":"Toussirot E, Wendling D, Tiberghien P et al. (2000) Decreased T cell precursor frequencies to Epstein-Barr virus glycoprotein Gp110 in peripheral blood correlate with disease activity and severity in patients with rheumatoid arthritis. Ann Rheum Dis 59: 533\u2013538","journal-title":"Ann Rheum Dis"},{"key":"105_CR30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00296-002-0229-4","volume":"22","author":"Varoczy","year":"2002","unstructured":"Varoczy L, Gergely L, Zeher M et al. (2002) Malignant lymphoma-associated autoimmune diseases \u2013 a descriptive epidemiological study. Rheumatol Int 22: 233\u2013237 (Epub 2002 Aug 29)","journal-title":"Rheumatol Int"},{"key":"105_CR31","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/art.21674","volume":"54","author":"Weyand","year":"2006","unstructured":"Weyand C, Goronzy J, Kurtin P (2006) Lymphoma in rheumatoid arthritis: an immune system set up for failure. Arthritis Rheum 54: 685\u2013689","journal-title":"Arthritis Rheum"},{"key":"105_CR32","doi-asserted-by":"crossref","unstructured":"Whelan J, Scadden D (2006) Cancer in the immunosuppressed patient. In: Chang AE (ed) Oncology: an evidence-based approach. Springer, New York","DOI":"10.1007\/0-387-31056-8_96"},{"key":"105_CR33","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/art.20311","volume":"50","author":"Wolfe","year":"2004","unstructured":"Wolfe F, Michaud K (2004) Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 50: 1740\u20131751","journal-title":"Arthritis Rheum"},{"key":"105_CR34","first-page":"1029","volume":"16","author":"Yokochi","year":"1989","unstructured":"Yokochi T, Yamagawa A, Kimura Y et al. (1989) High titer of antibody to the Epstein-Barr virus membrane antigen in sera from patients with rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 16: 1029\u20131032","journal-title":"J Rheumatol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-006-0105-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-006-0105-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-006-0105-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T12:29:37Z","timestamp":1559046577000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-006-0105-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["105"],"URL":"https:\/\/doi.org\/10.1007\/s00393-006-0105-9","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}